8-K ·Filed May 1, 2026

CRIS

CURIS INC
BEARISH
Impact 8/10
Horizonimmediate Processed5mo ago SEC0001108205-26-000056
8-K context-dependent: Items 3.01
Actionable Insight ▼ Bearish

Traders should expect high volatility ahead of the May 4 appeal deadline and May 6 suspension date. If the appeal is denied or the hearing fails, delisting would likely trigger a sharp sell-off in an already distressed stock. Monitor for any reverse split announcement or capital raise as potential compliance strategies.

DirectionBearish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
CRIS ▼ -57.07% at T+60d
SHORT call ✓ call won +57.07% · α vs SPY +58.93% · entry $11.60 → $4.98
Entry anchored
May 1, 2026
via day open
T+1d
-1.72%
call +1.72% · α +2.53%
$11.40
settled 5mo ago
T+5d
-5.17%
call +5.17% · α +8.14%
$11.00
settled 5mo ago
T+20d
-13.79%
call +13.79% · α +19.58%
$10.00
settled 4mo ago
T+60d
-57.07%
call +57.07% · α +58.93%
$4.98
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Curis received a Nasdaq delisting determination letter on April 27, 2026, because its common stock bid price closed below $1.00 for 30 consecutive business days. The company intends to appeal by requesting a hearing before May 4, 2026, which would stay the suspension scheduled for May 6, but there is no assurance the appeal will succeed. This filing follows a prior discretionary panel monitor period, meaning Curis has limited procedural flexibility to regain compliance.

Key Facts

  • Nasdaq issued a Delist Determination Letter on April 27, 2026 for non-compliance with the $1.00 minimum bid price rule (Listing Rule 5550(a)(2)).
  • Stock had closed below $1.00 for 30 consecutive business days.
  • Trading suspension scheduled for May 6, 2026 unless an appeal is filed by May 4, 2026.
  • Company was already under a one-year Discretionary Panel Monitor (since Feb 3, 2026), limiting its ability to request additional compliance periods.
  • Company intends to request a hearing to stay delisting, but success is uncertain.
  • Market cap is approximately $24M, making the company highly vulnerable to delisting consequences.

Financial Impact

Delisting would severely reduce institutional ownership and liquidity for a $24M market cap company. No specific financial figures provided in filing.

liquidityinstitutional ownershipstock price

Risk Factors

  • Delisting would cut off institutional access and severely reduce liquidity.
  • Company is already under a Panel Monitor, limiting its ability to negotiate compliance extensions.
  • No guarantee the Nasdaq hearing panel will grant continued listing.
  • At $24M market cap, the company has limited financial flexibility to engineer a compliance solution.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001108205-26-000056
Document: 0001108205-26-000056-index-headers.html0001108205-26-000056
Document: 0001108205-26-000056-index.html0001108205-26-000056
Document: 0001108205-26-000056.txt0001108205-26-000056
7 reports for CRIS
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +82.45%May 22, 2026
Filters
Rows
Reports for CRIS — sortable, filterable
TypeNow
Aug 13, 2026
7w ago
EFFECT
BEARISH ★ 6/10
$1.87 $1.13▲ +39.57%▲ +37.83%$0.8034 (+57.04%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 6/10
$5.02 $1.49▼ −70.32%▼ −73.31%$0.8034 (−84.00%)
Jul 2, 2026
13w ago
8-K
NEUTRAL ★ 3/10
$0.3466 $4.96▲ +1331.04%▲ +1331.46%$0.8034 (+131.79%)
May 22, 2026
19w ago
8-K
BEARISH ★ 6/10
$9.80 $6.80▲ +30.61%▲ +28.55%$0.8034 (+91.80%)
May 12, 2026
20w ago
8-K
BEARISH ★ 7/10
$10.00 $8.60▲ +14.00%▲ +13.39%$0.8034 (+91.97%)
May 1, 2026
22w ago
8-K
BEARISH ★ 8/10
$11.60 $10.00▲ +13.79%▲ +19.58%$0.8034 (+93.07%)
Mar 23, 2026
27w ago
EFFECT
NEUTRAL ★ 4/10
$0.7400 $0.6000▼ −18.92%▼ −26.34%$0.8034 (+8.57%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (37h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access